Clinical trial
Zileuton to Treat Adults With Chronic Obstructive Pulmonary Disease (The LEUKO…
NCT00493974 · University of Minnesota, Other · Terminated
Key facts
| NCT number | NCT00493974 |
|---|---|
| Title | Zileuton to Treat Adults With Chronic Obstructive Pulmonary Disease (The LEUKO Study) |
| Official title | Antileukotriene Therapy for COPD Exacerbations |
| Acronym | LEUKO |
| Lead sponsor | University of Minnesota, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug |
| Interventions | Zileuton, Placebo |
| Enrollment | 119 |
| Start date | Mar 1, 2007 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Jun 29, 2007 |
| Last update posted | Nov 18, 2019 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: